查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786949

抗體探索市場，規模，佔有率，趨勢，產業分析報告:各方法，抗體類別，各終端用戶，各地區-2025～2034年市場預測

Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，抗體發現市場規模將達到 204.1 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

抗體發現是識別和開發特異性結合病毒、細菌和癌細胞等標靶的抗體的過程。有效抗體的分離和優化通常使用雜交瘤技術、噬菌體展示和單一 B 細胞篩選等技術。之後，研究人員對這些抗體進行表徵和測試，以確定其在診斷、治療或研究中的潛在用途。

個人化醫療正在改變疾病的治療方式，其重點是針對個別基因組成和病理進行量身定制的治療方案。抗體在這一方法中發揮關鍵作用，因為它們可以被設計成靶向體內特定分子，例如癌細胞中的分子。隨著越來越多的人和醫生傾向於更精準、副作用更少的治療，對客製化抗體療法的需求也日益增長。這種轉變在腫瘤學等領域尤其重要，因為沒有哪兩個患者對治療的反應完全相同。抗體發現技術能夠識別和開發針對不同患者群體的高度特異性治療方法。這一趨勢正鼓勵製藥公司加大對個人化治療研究的投入。隨著個人化醫療的認知度和成功案例的增多，抗體發現市場將持續發展，並成為未來醫療保健的關鍵。

生技公司、大型製藥公司、學術機構和實驗室之間的策略聯盟在抗體發現的推進中發揮著重要作用。這種夥伴關係使不同的組織能夠共享資源、知識和技術，使藥物發現過程更快、更有效率。實驗室可能擁有先進的技術設備，而製藥公司可能擁有資金和生產能力。合作研究也有助於管理與藥物開發相關的高成本和風險。目前，許多公司正在簽訂共同開發和授權協議，以共享利益和責任。這一趨勢推動著越來越多的抗體藥物進入臨床試驗並最終惠及患者。

抗體發現市場報告重點

到2024年，噬菌體展示技術將佔最大的市場佔有率，因為它具有多功能性、可靠性以及在相對較短的時間內生產高親和力抗體的能力。

由於人們越來越關注開發包括單株抗體在內的生物製劑，以治療包括癌症、自體免疫疾病和傳染病在內的多種疾病，預計製藥生物技術產業將在預測期內經歷顯著增長。

到2024年，由於強大的生物醫學研究基礎設施和對生命科學的持續投資，北美將佔抗體發現市場的最大佔有率。

由於生技產業的擴張、政府的支持以及對醫療保健研究的投入增加，亞太抗體發現市場正在經歷顯著成長。

全球主要市場參與者包括 Biocytogen、Charles River Laboratories、Creative Biolabs、Danaher Corporation、Eurofins Scientific、Evotec、Fairjourney Biologics S.A.、Genscript Technology Corporation、Sartorius AG 和 Twist Bioscience。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 全球抗體發現市場洞察

  • 市場概述
  • 抗體發現市場動態
    • 促進因素和機會
      • 慢性病和傳染病的流行
      • 生物製藥研發投入的增加
    • 限制因素與挑戰
      • 初始製造成本高
  • PESTEL分析
  • 抗體發現市場趨勢
  • 價值鏈分析

第5章 全球抗體發現市場:各方法

  • 主要調查結果
  • 簡介
  • 噬菌體顯示器
  • 融合瘤
  • 其他

第6章 全球抗體發現市場:抗體類別

  • 主要調查結果
  • 簡介
  • 人體化抗體
  • 人抗體
  • 嵌合抗體
  • 鼠標抗體

第7章 全球抗體發現市場:各終端用戶

  • 主要調查結果
  • 簡介
  • 製藥生物科技產業
  • 實驗室
  • 學術實驗室

第8章 全球抗體發現市場:地區

  • 主要調查結果
  • 簡介
    • 抗體發現市場評估:地區，2020～2034年
  • 北美
    • 北美:各方法，2020～2034年
    • 北美:抗體類別，2020～2034年
    • 北美:各終端用戶，2020～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各方法，2020～2034年
    • 歐洲:抗體類別，2020～2034年
    • 歐洲:各終端用戶，2020～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他的歐洲
  • 亞太地區
    • 亞太地區:各方法，2020～2034年
    • 亞太地區:抗體類別，2020～2034年
    • 亞太地區:各終端用戶，2020～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他的亞太地區
  • 中東·非洲
    • 中東·非洲:各方法，2020～2034年
    • 中東·非洲:抗體類別，2020～2034年
    • 中東·非洲:各終端用戶，2020～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他的中東·非洲
  • 南美
    • 南美:各方法，2020～2034年
    • 南美:抗體類別，2020～2034年
    • 南美:各終端用戶，2020～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他的南美

第9章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Biocytogen
  • Charles River Laboratories
  • Creative Biolabs
  • Danaher Corporation
  • Eurofins Scientific
  • Evotec
  • Fairjourney Biologics S.A
  • Genscript Technology Corporation
  • Sartorius AG
  • Twist Bioscience
Product Code: PM5947

The antibody discovery market size is expected to reach USD 20.41 billion by 2034, according to a new study by Polaris Market Research. The report "Antibody Discovery Market Size, Share, Trends, Industry Analysis Report By Method (Phage Display, Hybridoma, Other), By Antibody Type, By End User, By Region- Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Antibody discovery is the process of identifying and developing antibodies that can specifically bind to a target, such as a virus, bacterium, or cancer cell. It involves techniques such as hybridoma technology, phage display, or single B-cell screening to isolate and optimize effective antibodies. These antibodies are then characterized and tested for their potential use in diagnostics, therapeutics, or research.

Personalized medicine is transforming the way diseases are treated by focusing on therapies that are tailored to an individual's genetic makeup and condition. Antibodies play a key role in this approach as they can be engineered to target specific molecules in the body, such as those found in cancer cells. The demand for customized antibody therapies is rising as more people and doctors prefer treatments that are more precise and have fewer side effects. This shift is especially important in fields such as oncology, where no two patients respond exactly the same way to treatment. Antibody discovery technologies enable the identification and development of highly specific treatments tailored to different patient groups. This trend is encouraging pharmaceutical companies to invest more in research that supports personalized approaches. As awareness and success stories around personalized medicine grow, it pushes the antibody discovery market forward, making it an essential part of future healthcare.

Strategic collaborations between biotech companies, pharmaceutical giants, academic institutions, and research labs are playing a big role in advancing antibody discovery. These partnerships allow different organizations to share resources, knowledge, and technology, making the discovery process faster and more effective. A research lab may have an advanced technological setup, while a pharmaceutical company may have the funding and manufacturing capabilities. Collaborations further help in managing the high cost and risk associated with drug development. Many companies now enter co-development or licensing agreements to share profits and responsibilities. This trend has led to a growing number of antibody-related drugs entering clinical trials and eventually reaching patients.

Antibody Discovery Market Report Highlights

In 2024, the phage display segment dominated with the largest share due to its versatility, reliability, and ability to produce high-affinity antibodies in a relatively short time.

The pharmaceutical and biotechnology industry segment is expected to experience significant growth during the forecast period as these companies are increasingly focused on developing biologic drugs, including monoclonal antibodies, to treat a wide range of conditions such as cancer, autoimmune diseases, and infectious diseases.

In 2024, North America dominated the antibody discovery market with the largest share due to its strong biomedical research infrastructure and consistent investments in life sciences.

The Asia Pacific antibody discovery market is experiencing significant growth driven by expanding biotech industries, supportive government initiatives, and increasing investments in healthcare research.

A few global key market players are Biocytogen, Charles River Laboratories, Creative Biolabs, Danaher Corporation, Eurofins Scientific, Evotec, Fairjourney Biologics S.A, Genscript Technology Corporation, Sartorius AG, and Twist Bioscience.

Polaris Market Research has segmented the antibody discovery market report on the basis of method, antibody type, end user, and region:

By Method (Revenue - USD Billion, 2020-2034)

Phage Display

Hybridoma

Others

By Antibody Type (Revenue - USD Billion, 2020-2034)

Humanized Antibody

Human Antibody

Chimeric Antibody

Murine Antibody

By End User (Revenue - USD Billion, 2020-2034)

Pharmaceutical and Biotechnology industry

Research laboratory

Academic laboratory

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Rest of Europe

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Australia

Rest of Asia Pacific

Latin America

Argentina

Brazil

Rest of Latin America

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Antibody Discovery Market Insights

  • 4.1. Antibody Discovery Market - Market Snapshot
  • 4.2. Antibody Discovery Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing Prevalence of Chronic and Infectious Disease
      • 4.2.1.2. Increase in Investment in Biopharmaceutical R&D
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Cost of Manufacturing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Antibody Discovery Market Trends
  • 4.6. Value Chain Analysis

5. Global Antibody Discovery Market, by Method

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • 5.3. Phage Display
    • 5.3.1. Global Antibody Discovery Market, by Phage Display, by Region, 2020-2034 (USD billion)
  • 5.4. Hybridoma
    • 5.4.1. Global Antibody Discovery Market, by Hybridoma, by Region, 2020-2034 (USD billion)
  • 5.5. Others
    • 5.5.1. Global Antibody Discovery Market, by Others, by Region, 2020-2034 (USD billion)

6. Global Antibody Discovery Market, by Antibody Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • 6.3. Humanized Antibody
    • 6.3.1. Global Antibody Discovery Market, by Humanized Antibody, by Region, 2020-2034 (USD billion)
  • 6.4. Human Antibody
    • 6.4.1. Global Antibody Discovery Market, by Human Antibody, by Region, 2020-2034 (USD billion)
  • 6.5. Chimeric Antibody
    • 6.5.1. Global Antibody Discovery Market, by Chimeric Antibody, by Region, 2020-2034 (USD billion)
  • 6.6. Murine Antibody
    • 6.6.1. Global Antibody Discovery Market, by Murine Antibody, by Region, 2020-2034 (USD billion)

7. Global Antibody Discovery Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 7.3. Pharmaceutical and Biotechnology industry
    • 7.3.1. Global Antibody Discovery Market, by Pharmaceutical and Biotechnology industry, by Region, 2020-2034 (USD billion)
  • 7.4. Research laboratory
    • 7.4.1. Global Antibody Discovery Market, by Research laboratory, by Region, 2020-2034 (USD billion)
  • 7.5. Academic laboratory
    • 7.5.1. Global Antibody Discovery Market, by Academic laboratory, by Region, 2020-2034 (USD billion)

8. Global Antibody Discovery Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
  • 8.3. Antibody Discovery Market - North America
    • 8.3.1. North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.3.2. North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.3.3. North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.3.4. Antibody Discovery Market - U.S.
      • 8.3.4.1. U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.3.4.2. U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.3.4.3. U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.3.5. Antibody Discovery Market - Canada
      • 8.3.5.1. Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.3.5.2. Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.3.5.3. Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.4. Antibody Discovery Market - Europe
    • 8.4.1. Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.4.2. Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.4.3. Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.4. Antibody Discovery Market - UK
      • 8.4.4.1. UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.4.2. UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.4.3. UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.5. Antibody Discovery Market - France
      • 8.4.5.1. France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.5.2. France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.5.3. France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.6. Antibody Discovery Market - Germany
      • 8.4.6.1. Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.6.2. Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.6.3. Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.7. Antibody Discovery Market - Italy
      • 8.4.7.1. Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.7.2. Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.7.3. Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.8. Antibody Discovery Market - Spain
      • 8.4.8.1. Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.8.2. Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.8.3. Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.9. Antibody Discovery Market - Netherlands
      • 8.4.9.1. Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.9.2. Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.9.3. Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.10. Antibody Discovery Market - Russia
      • 8.4.10.1. Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.10.2. Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.10.3. Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.4.11. Antibody Discovery Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.4.11.2. Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.4.11.3. Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.5. Antibody Discovery Market - Asia Pacific
    • 8.5.1. Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.5.2. Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.5.3. Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.4. Antibody Discovery Market - China
      • 8.5.4.1. China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.4.2. China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.4.3. China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.5. Antibody Discovery Market - India
      • 8.5.5.1. India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.5.2. India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.5.3. India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.6. Antibody Discovery Market - Malaysia
      • 8.5.6.1. Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.6.2. Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.6.3. Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.7. Antibody Discovery Market - Japan
      • 8.5.7.1. Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.7.2. Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.7.3. Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.8. Antibody Discovery Market - Indonesia
      • 8.5.8.1. Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.8.2. Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.8.3. Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.9. Antibody Discovery Market - South Korea
      • 8.5.9.1. South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.9.2. South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.9.3. South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.10. Antibody Discovery Market - Australia
      • 8.5.10.1. Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.10.2. Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.10.3. Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.5.11. Antibody Discovery Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.5.11.2. Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.5.11.3. Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.6. Antibody Discovery Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.6.2. Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.6.3. Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.4. Antibody Discovery Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.4.2. Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.4.3. Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.5. Antibody Discovery Market - UAE
      • 8.6.5.1. UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.5.2. UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.5.3. UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.6. Antibody Discovery Market - Israel
      • 8.6.6.1. Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.6.2. Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.6.3. Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.7. Antibody Discovery Market - South Africa
      • 8.6.7.1. South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.7.2. South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.7.3. South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.6.8. Antibody Discovery Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.6.8.2. Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.6.8.3. Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • 8.7. Antibody Discovery Market - Latin America
    • 8.7.1. Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
    • 8.7.2. Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
    • 8.7.3. Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.4. Antibody Discovery Market - Mexico
      • 8.7.4.1. Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.4.2. Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.4.3. Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.5. Antibody Discovery Market - Brazil
      • 8.7.5.1. Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.5.2. Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.5.3. Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.6. Antibody Discovery Market - Argentina
      • 8.7.6.1. Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.6.2. Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.6.3. Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
    • 8.7.7. Antibody Discovery Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
      • 8.7.7.2. Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
      • 8.7.7.3. Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Biocytogen
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Method Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Charles River Laboratories
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Method Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Creative Biolabs
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Method Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Method Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Eurofins Scientific
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Method Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Evotec
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Method Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Fairjourney Biologics S.A
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Method Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Genscript Technology Corporation
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Method Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Sartorius AG
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Method Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Twist Bioscience
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Method Benchmarking
    • 10.10.4. Recent Development

List of Tables:

  • Table 1 Global Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 2 Global Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 3 Global Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 4 North America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 5 North America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 6 North America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 7 U.S.: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 8 U.S.: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 9 U.S.: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 10 Canada: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 11 Canada: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 12 Canada: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 13 Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 14 Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 15 Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 16 UK: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 17 UK: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 18 UK: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 19 France: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 20 France: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 21 France: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 22 Germany: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 23 Germany: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 24 Germany: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 25 Italy: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 26 Italy: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 27 Italy: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 28 Spain: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 29 Spain: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 30 Spain: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 31 Netherlands: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 32 Netherlands: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 33 Netherlands: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 34 Russia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 35 Russia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 36 Russia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 37 Rest of Europe: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 38 Rest of Europe: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 39 Rest of Europe: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 40 Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 41 Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 42 Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 43 China: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 44 China: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 45 China: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 46 India: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 47 India: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 48 India: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 49 Malaysia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 50 Malaysia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 51 Malaysia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 52 Japan: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 53 Japan: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 54 Japan: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 55 Indonesia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 56 Indonesia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 57 Indonesia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 58 South Korea: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 59 South Korea: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 60 South Korea: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 61 Australia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 62 Australia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 63 Australia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 64 Rest of Asia Pacific: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 65 Rest of Asia Pacific: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 66 Rest of Asia Pacific: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 67 Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 68 Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 69 Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 70 Saudi Arabia: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 71 Saudi Arabia: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 72 Saudi Arabia: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 73 UAE: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 74 UAE: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 75 UAE: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 76 Israel: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 77 Israel: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 78 Israel: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 79 South Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 80 South Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 81 South Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 82 Rest of Middle East & Africa: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 83 Rest of Middle East & Africa: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 84 Rest of Middle East & Africa: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 85 Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 86 Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 87 Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 88 Mexico: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 89 Mexico: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 90 Mexico: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 91 Brazil: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 92 Brazil: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 93 Brazil: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 94 Argentina: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 95 Argentina: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 96 Argentina: Antibody Discovery Market, by End User, 2020-2034 (USD billion)
  • Table 97 Rest of Latin America: Antibody Discovery Market, by Method, 2020-2034 (USD billion)
  • Table 98 Rest of Latin America: Antibody Discovery Market, by Antibody Type, 2020-2034 (USD billion)
  • Table 99 Rest of Latin America: Antibody Discovery Market, by End User, 2020-2034 (USD billion)

List of Figures:

  • Figure 1. Global Antibody Discovery Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Method
  • Figure 7. Global Antibody Discovery Market, by Method, 2024 & 2034 (USD billion)
  • Figure 8. Market by Antibody Type
  • Figure 9. Global Antibody Discovery Market, by Antibody Type, 2024 & 2034 (USD billion)
  • Figure 10. Market by End User
  • Figure 11. Global Antibody Discovery Market, by End User, 2024 & 2034 (USD billion)
  • Figure 12. Global Antibody Discovery Market Assessment, By Geography, 2020-2034 (USD billion)
  • Figure 13. Strategic Analysis - Global Antibody Discovery Market